Author: OurCrowd

[OncoHost in Onco’Zine] A multicomponent biomarker approach will shift cancer care

Jun 12, 2023 |

For many years we have been working towards creating a paradigm shift in cancer care, and precision oncology is rapidly evolving, with the potential to revolutionize our current standards and guidelines. But while we have made giant strides in our understanding of the disease, the current approach to biomarker development is still simplistic and fragmented, limiting our ability to understand the underlying biology of the patient’s cancer, tailor treatment to individual patients, monitor treatment response, detect early signs of relapse, and identify potential new targets for therapy. True precision oncology requires a comprehensive and integrated approach to biomarker development to really make a dent. Read...

Read More

[The Global Health Equity Fund in Sojitz] Sojitz signs memorandum of understanding for strategic alliance with HIROTSU Bioscience, WHO Foundation, OurCrowd and Global Health Equity Fund

Jun 12, 2023 |

June 12, 2023 Sojitz Corporation (“Sojitz”) signed a memorandum of understanding with HIROTSU Bioscience Inc.(“HIROTSU”), a developer and provider of N-NOSE®, a primary cancer screening test is a revolutionary offering for early cancer detection, the WHO Foundation (“WHO Foundation”), OurCrowd, a venture capital firm and the Global Health Equity Fund (“GHEF”), a fund that invests in innovative new medical technologies to tackle health inequity to jointly conduct strategic alliances and feasibility studies for the deployment of N-NOSE® in low and middle-income countries and regions. Read more...

Read More

[Stellar Cyber in Business Wire] Stellar Cyber and Mimecast partner to deliver automated, scalable phishing attack mitigation solution

Jun 12, 2023 |

SAN JOSE, Calif.–(BUSINESS WIRE)–Stellar Cyber, the innovator of Open XDR, today announced a new technology partnership with Mimecast, an advanced email and collaboration security company. This powerful technology integration makes it easy for Stellar Cyber and Mimecast customers to swiftly mitigate the risk of damaging email-based attacks, such as phishing attacks, by automating the sharing of vital attack data between the two solutions, reducing attacker dwell time and speeding response. Read more...

Read More

[Plantish in PR Newswire] Plantish announces rebranding to Oshi, sets its sights on US restaurants and forges partnership with top EU retailer coop

Jun 12, 2023 |

REHOVOT, Israel, June 12, 2023 /PRNewswire/ — Plantish, the pioneering company known for its revolutionary plant-based salmon created through patent-pending additive manufacturing technology, is excited to announce its rebranding to Oshi, effective immediately. This name change marks a significant milestone in Oshi’s broader strategic transformation into a global food company as it gears up for the highly anticipated product launch in the United States later this year. Read more...

Read More